午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook--->CAS DataBase List--->103890-78-4

103890-78-4

103890-78-4 Structure

103890-78-4 Structure
IdentificationMore
[Name]

Lacidipine
[CAS]

103890-78-4
[Synonyms]

CALDINE
(E)-4-[2-[3-(1,1-DIMETHYLETHOXY)-3-OXO-1-PROPENYL]PHENYL]-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
GR-43659X
GX-1048
LACIDIPINE
LACIDIPINE-D9
LACIPIL
LACIREX
MOTENS
3,5-pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(2-(3-(1,1-dimethylet
diethylester,(e)-hoxy)-3-oxo-1-propenyl)phenyl)
Lacidipin
LACIDIPINE, IMPURITY STANDARD BP STANDARD
LACIDIPINE, BP STANDARD
LACIDIPINE ASSAY STANDARD BP(CRM STANDARD)
LACIDIPINE BP STANDARD(CRM STANDARD)
LACIDIPINE IMPURITY STANDARD BP STANDARD(CRM STANDARD)
LACIDIPINE IMPURITY STANDARD BP(CRM STANDARD)
LacidipineC26H33N06
(E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester, GR-43659X, GX-1048, Caldine, Lacipil, Lacirex, Motens
[EINECS(EC#)]

638-759-0
[Molecular Formula]

C26H33NO6
[MDL Number]

MFCD00865936
[Molecular Weight]

455.54
[MOL File]

103890-78-4.mol
Chemical PropertiesBack Directory
[Appearance]

White-to-Off-White Crystalline Solid
[Melting point ]

174-175°C
[Boiling point ]

558.4±50.0 °C(Predicted)
[density ]

1.127±0.06 g/cm3(Predicted)
[storage temp. ]

2-8°C
[solubility ]

DMSO: soluble20mg/mL, clear
[form ]

powder
[pka]

3.00±0.70(Predicted)
[color ]

white to beige
[Usage]

A dihydropyridine calcium channel blocker. Antihypertensive
[Merck ]

14,5331
[InChI]

InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+
[InChIKey]

GKQPCPXONLDCMU-CCEZHUSRSA-N
[SMILES]

C1(C)NC(C)=C(C(OCC)=O)C(C2=CC=CC=C2/C=C/C(OC(C)(C)C)=O)C=1C(OCC)=O
[CAS DataBase Reference]

103890-78-4(CAS DataBase Reference)
Safety DataBack Directory
[Hazard Codes ]

Xn
[Risk Statements ]

22
[WGK Germany ]

3
[RTECS ]

US7970200
[Toxicity]

mouse,LD50,intraperitoneal,80200ug/kg (80.2mg/kg),SKIN AND APPENDAGES (SKIN): HAIR: OTHERSENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYEBEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY),Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 22, Pg. 335, 1994.
Raw materials And Preparation ProductsBack Directory
[Raw materials]

Triphenylphosphine-->trans-Cinnamic acid-->tert-Butyl acetate-->o-Phthalaldehyde-->tert-Butyl acrylate-->(tert-Butoxycarbonylmethyl)triphenylphosphanium bromide-->ETHYL 3-AMINOCROTONATE-->Sodium hydroxide-->Isopropyl alcohol
Material Safety Data Sheet(MSDS)Back Directory
[msds information]

Lacidipine(103890-78-4).msds
Hazard InformationBack Directory
[Description]

Lacidipine is a new second-generation dihydropyridine calcium antagonist introduced as a once a day treatment for mild to moderate hypertension. It is reported to have high selectivity for vascular smooth muscle and also a long duration of action. The use of lacidipine as an antiatherosclerotic agent is currently under investigation.
[Chemical Properties]

White-to-Off-White Crystalline Solid
[Originator]

Glaxo (United Kingdom)
[Uses]

A dihydropyridine calcium channel blocker. Antihypertensive
[Uses]

antihypertensive;dihydropyridinr calcium channel blocker
[Definition]

ChEBI: Lacidipine is a cinnamate ester and a tert-butyl ester.
[Brand name]

Lacipil; Lacirex; Viapres
[Biochem/physiol Actions]

Lacidipine is a long-acting calcium antagonist that is used in the management of hypertension. Lacidipine is a L-type Ca(2+) channel blocker belonging to 1,4-dihydropyridine class. Also, Lacidipine inhibits ryanodine receptors on the ER membrane that enhances folding, trafficking and lysosomal activity of ERAD (ER-associated degradation) misfolded lysosomal glucocerebrosidase (GS).
[Clinical Use]

#N/A
[Synthesis]

(tert-Butoxycarbonylmethyl)triphenylphosphanium bromide

59159-39-6

ETHYL 3-AMINOCROTONATE

626-34-6

o-Phthalaldehyde

643-79-8

Lacidipine

103890-78-4

1. 18 liters of dichloromethane were added to the reactor, followed by 5 kg of tert-butoxycarbonylmethyltriphenylphosphonium bromide (prepared with reference to Example 1). 2. 2.05 kg of o-phthalaldehyde was added, followed by 1 liter of dichloromethane, and the mixture was stirred for about 15 minutes, then cooled to -5°C. 3. A solution of 2.65 kg of sodium hydroxide flakes in 5 liters of water (pre-prepared at 25°C) was added to the reaction mixture at -3°C and kept at -3°C for 2.5 hours. The reaction process was monitored by thin layer chromatography. 4. After completion of the reaction, the mixture was warmed up to 25°C and stirring was continued for 30 minutes. The organic layer was separated and the solvent was removed by atmospheric pressure distillation at 52°C. The residue was kept at 52°C for 15 minutes. 5. 35 liters of n-heptane were added and 4 liters of n-heptane were distilled under 500 mmHg vacuum and at 63 °C. The mixture was then cooled to 0°C and held at 35°C for 1.5 hours. 6. The insoluble material was removed by vacuum filtration and the filter cake was washed with 7.5 liters of n-heptane. The filtrate was transferred to another reactor and the solvent was removed by complete distillation under vacuum at 610 mmHg and 68°C. 7. Cooled to 33 °C, 11.5 liters of isopropanol was added and subsequently cooled to -7 °C. 8. At -7 °C, a solution of 4.25 kg ethyl 3-aminocrotonate in 12.5 liters of isopropanol was slowly added, followed by 2.8 liters of trifluoroacetic acid and 1 liter of isopropanol, and the reaction was kept at -7 °C for 2 hours and 45 minutes. The reaction process was monitored by thin layer chromatography. 9. A solution of 2.6 kg of sodium bicarbonate in 50 liters of water was added to the reaction mixture at 0 °C, followed by 25 liters of ethyl acetate. Increase the temperature to 25°C and stir for 20 minutes. Separate the aqueous layer and extract with 12.5 liters of ethyl acetate. The organic layers were combined and the solvent was removed by atmospheric pressure distillation at 81 °C. 10. Add 5 liters of isopropanol to the residue and distill completely to remove the solvent. This operation is repeated once. Finally, the residue was dissolved in 63 liters of isopropanol and heated to 85°C to obtain a clarified solution. 11. Cool to 2 °C, keep for 1.5 h. Separate the solid by filtration and wash with 2.5 liters of isopropanol. The wet product was dried at 50°C for 30 minutes. 12. The dried substance was added to 23 liters of isopropanol, heated to 65°C and held for 30 minutes, cooled to 2°C and held for 1 hour, filtered and washed with 1.5 liters of isopropanol. 13. The wet solid was dried at 60 °C and 630 mmHg under vacuum for 5 h to give 2.04 kg of ethyl (E)-diethyl 4-(2-(3-(tert-butoxy)-3-oxoprop-1-en-1-yl)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate in 40.9% yield. The content of triphenylphosphine oxide was less than 0.0011 area%.

[Drug interactions]

Potentially hazardous interactions with other drugs Aminophylline and theophylline: possibly increased aminophylline and theophylline concentration. Anaesthetics: enhanced hypotensive effect. Antibacterials: metabolism possibly inhibited by clarithromycin, erythromycin and telithromycin. Antidepressants: enhanced hypotensive effect with MAOIs. Antiepileptics: effect possibly reduced by carbamazepine, barbiturates, phenytoin and primidone. Antifungals: metabolism possibly inhibited by itraconazole and ketoconazole; negative inotropic effect possibly increased with itraconazole. Antihypertensives: enhanced hypotensive effect, increased risk of first dose hypotensive effect of postsynaptic alpha-blockers. Antivirals: concentration possibly increased by ritonavir. Ciclosporin: 10 kidney transplant patients on ciclosporin, prednisone and azathioprine were given 4 mg lacidipine daily. A very small increase in the trough serum levels (+6%) and AUC (+14%) of the ciclosporin occurred. Grapefruit juice: concentration increased - avoid concomitant use
[Metabolism]

Lacidipine undergoes extensive first-pass metabolism in the liver. The drug is eliminated primarily by hepatic metabolism (involving cytochrome P450 CYP3A4). The principal metabolites possess little, if any, pharmacodynamic activity. Approximately 70% of the administered dose is eliminated as metabolites in the faeces and the remainder as metabolites in the urine.
[References]

[1] Patent: US2007/43088, 2007, A1. Location in patent: Page/Page column 6
Spectrum DetailBack Directory
[Spectrum Detail]

Lacidipine(103890-78-4)1HNMR
103890-78-4 suppliers list
Company Name: Henan Bao Enluo International TradeCo.,LTD
Tel: +86-17331933971
Website: baoenluo.guidechem.com/
Company Name: Moxin Chemicals
Tel: +8617320513646 , +8617320513646
Website: www.molcoo.com/
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512 , +86-19937530512
Website: https://www.tianfuchem.com/
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695 , +8613203830695
Website: www.coreychem.com/
Company Name: Shandong chuangyingchemical Co., Ltd.
Tel: 18853181302
Website: www.yuhua99.com/ShowSupplierProductsList103425/0_EN.htm
Company Name: BOC Sciences
Tel: +1-631-485-4226
Website: www.bocsci.com/
Company Name: Shanghai Longyu Biotechnology Co., Ltd.
Tel: +8619521488211 , +8619521488211
Website: www.yuhua99.com/manufacturer/shanghai-longyu-biotechnology-164/
Company Name: CONIER CHEM AND PHARMA LIMITED
Tel: +8618523575427 , +8618523575427
Website: http://www.conier.com/
Company Name: Hebei Mujin Biotechnology Co.,Ltd
Tel: +86-13288715578
Website:
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354 , +17819995354
Website: https://www.targetmol.com/
Company Name: Hubei Ipure Biology Co., Ltd
Tel: +8613367258412 , +8613367258412
Website: www.ipurechemical.com
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226 , 13588875226
Website: www.hzclap.com/en
Company Name: Shaanxi Dideu Medichem Co. Ltd
Tel: +86-029-89586680 +86-18192503167 , +86-18192503167
Website: www.dideu.com
Company Name: AFINE CHEMICALS LIMITED
Tel: +86-0571-85134551
Website: www.afinechem.com/index.html
Company Name: Wuhan Fortuna Chemical Co., Ltd
Tel: +86-027-59207850 +86-13986145403; , +86-13986145403;
Website: http://www.fortunachem.com/
Company Name: Baoji Guokang Bio-Technology Co., Ltd.
Tel: 0917-3909592 13892490616 , 13892490616
Website: http://www.gk-bio.com
Company Name: Baoji Guokang Healthchem co.,ltd
Tel: +8615604608665 15604608665 , 15604608665
Website: www.gk-bio.com
Company Name: Sinoway Industrial co., ltd.
Tel: 0592-5800732; +8613806035118 , +8613806035118
Website: https://www.china-sinoway.com/
Tags:103890-78-4 Related Product Information
76-87-9 3332-29-4 118-55-8 91-53-2 462-95-3 101-84-8 103-82-2 7782-44-7 103890-78-4

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.